Top Markets
#1 Bitcoin TRC20 Bitcoin TRC20 +11.31%
#2 Seeker Seeker +8.57%
#3 Cash Cat Cash Cat +6.38%
#4 龙虾 (Lobster) 龙虾 (Lobster) +6.01%
#5 Pons Pons +5.82%
#6 Arbitrum Arbitrum +5.71%
#7 Siacoin Siacoin +5.70%
#8 Story Story +5.50%
#9 Pump.fun Pump.fun +5.01%
#10 Unit Pump Unit Pump +5.01%
Coin of the day
Bitcoin TRC20 Bitcoin TRC20
설정
언어
한국어
통화
USD
테마
Valerio Therapeutics S.A. Valerio Therapeutics S.A.

Valerio Therapeutics S.A.

ALVIO
주식 순위 #14050
Headquartered in Paris, France, and founded in 1997, Valerio Therapeutics S.A.... Headquartered in Paris, France, and founded in 1997, Valerio Therapeutics S.A. (known as Onxeo SA until June 2023) is a clinical-stage biotechnology company dedicated to the global research and development of oncology treatments. Their focus is on targeting the DNA repair processes crucial for tumor survival. The company's offerings include Beleodaq, an approved medication for peripheral T-cell lymphoma. Their development pipeline features AsiDNA, which is progressing through Phase 1 clinical trials for metastatic melanoma and is also being evaluated for relapsed ovarian cancer through a research collaboration with Gustave Roussy. Furthermore, Valerio Therapeutics is advancing OX401, a preclinical program targeting DNA damage response and immuno-oncology, along with its proprietary platON decoy oligonucleotide platform. The firm also holds a licensing agreement with Acrotech Biopharma LLC.
주가
$0.88012714
마지막 동기화: 2026-08-31
시가총액
$439.58M
변동 (1일)
-4.01%
변동 (1년)
1,131.97%
국가
FR
거래 Valerio Therapeutics S.A. (ALVIO)

카테고리

Healthcare
Valerio Therapeutics S.A. (ALVIO)의 주가 이력
최고 종가: $0.91 (2026-08-01 기준)

최저 종가: $0.28 (2023-06-01 기준)
Valerio Therapeutics S.A.의 주가 이력 (2023 ~ 2026)
연간 주가 성과
연도 성과
2026 (TTM) 53.06%
2025 116.87%
2024 -58.47%
2023 0.00%
유사 기업 또는 경쟁사의 주가
회사 주가 변동률 1년% 국가
Vertex Pharmaceuticals Incorporated Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
VRTX.US
 $544.38 39.22%
US
Argenx SE Argenx SE
Argenx SE
ARGX.US
 $1.03K 45.21%
NL
CSL Limited CSL Limited
CSL Limited
CSL.AX
 $122.88 -10.84%
AU
Moderna, Inc. Moderna, Inc.
Moderna, Inc.
MRNA.US
 $138.80 476.17%
US
Lonza Group AG Lonza Group AG
Lonza Group AG
LONN.SW
 $749.90 5.10%
CH